Pan; Zhuo-Hua

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pan; Zhuo-Hua.The latest application filed is for "identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof".

Company Profile

7.10.20

Pan; Zhuo-Hua - Troy MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Identification Of Mutations In Channelopsin Variants Having Improved Light Sensitivity And Methods Of Use Thereof App 20220089660 - Pan; Zhuo-Hua	2022-03-24
Aav-mediated Subcellular Targeting Of Heterologous Rhodopsins In Retinal Ganglion Cells App 20220040326 - PAN; Zhuo-Hua	2022-02-10
Identification Of Channelrhodopsin-2 (chr2) Mutations And Methods Of Use App 20220033449 - PAN; Zhuo-Hua	2022-02-03
Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof Grant 11,041,004 - Pan June 22, 2	2021-06-22
Restoration Of Visual Responses By In Vivo Delivery Of Rhodopsin Nucleic Acids App 20210100875 - PAN; Zhuo-Hua ; et al.	2021-04-08
Identification of channelrhodopsin-2 (ChR2) mutations and methods of use Grant 10,947,281 - Pan March 16, 2	2021-03-16
Method Of Enhancing Viral-mediated Gene Delivery App 20200368332 - PAN; Zhuo-Hua ; et al.	2020-11-26
Method Of Enhancing Delivery Of Therapeutic Compounds To The Eye App 20200268647 - PAN; Zhuo-Hua ; et al.	2020-08-27
Modified Mglur6 Promoter And Methods Of Use App 20200093938 - Pan; Zhuo-Hua ; et al.	2020-03-26
Identification Of Mutations In Channelopsin Variants Having Improved Light Sensitivity And Methods Of Use Thereof App 20190241628 - Pan; Zhuo-Hua	2019-08-08
Modified MGLUR6 promoter and methods of use Grant 10,307,492 - Pan , et al.	2019-06-04
Aav-mediated Subcellular Targeting Of Heterologous Rhodopsins In Retinal Ganglion Cells App 20190083651 - PAN; Zhuo-Hua	2019-03-21
Restoration of Visual Responses by In Vivo Delivery of Rhodopsin Nucleic Acids App 20180214513 - PAN; Zhuo-Hua ; et al.	2018-08-02
AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells Grant 9,968,689 - Pan May 15, 2	2018-05-15
Method of Enhancing Delivery of Therapeutic Compounds to the Eye App 20180064640 - PAN; Zhuo-Hua ; et al.	2018-03-08
Method Of Enhancing Viral-mediated Gene Delivery App 20170319669 - PAN; Zhuo-Hua ; et al.	2017-11-09
Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids Grant 9,730,981 - Pan , et al. August 15, 2	2017-08-15
Method of enhancing delivery of therapeutic compounds to the eye Grant 9,730,888 - Pan , et al. August 15, 2	2017-08-15
A Modified Mglur6 Promoter And Methods Of Use App 20170021038 - Pan; Zhuo-Hua ; et al.	2017-01-26
AAV-Mediated Subcellular Targeting of Heterologous Rhodopsins in Retinal Ganglion Cells App 20160354488 - Pan; Zhuo-Hua	2016-12-08
AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells Grant 9,453,241 - Pan September 27, 2	2016-09-27
Method of Enhancing Delivery of Therapeutic Compounds to the Eye App 20160038409 - Pan; Zhuo-Hua ; et al.	2016-02-11
Identification Of Channelrhodopsin-2 (chr2) Mutations And Methods Of Use App 20150044181 - Pan; Zhuo-hua	2015-02-12
Restoration of Visual Responses by In Vivo Delivery of Rhodopsin Nucleic Acids App 20140121265 - Pan; Zhuo-Hua ; et al.	2014-05-01
AAV-Mediated Subcellular Targeting of Heterologous Rhodopsins in Retinal Ganglion Cells App 20130259833 - Pan; Zhuo-Hua	2013-10-03
Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids Grant 8,470,790 - Pan , et al. June 25, 2	2013-06-25
Restoration Of Visual Responses By In Vivo Delivery Of Rhodopsin Nucleic Acids App 20100015095 - Pan; Zhuo-Hua ; et al.	2010-01-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.